Scantox Revenue and Competitors

Lille Skensved,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Scantox's estimated annual revenue is currently $25.6M per year.(i)
  • Scantox's estimated revenue per employee is $155,000

Employee Data

  • Scantox has 165 Employees.(i)
  • Scantox grew their employee count by 18% last year.

Scantox's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Scantox?

Scantox is a GLP-accredited pre-clinical contract research organization originally founded in 1977. Since 2021 Scantox is owned by the Nordic based investment company Impilo. Our focus is on providing high quality work within pharmacology, toxicology and histopathology. We service both global and local partners and are considered world leading within minipig toxicology.

keywords:N/A

N/A

Total Funding

165

Number of Employees

$25.6M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Scantox News

2022-03-22 - DI og Køge Kommune er enige om tættere samarbejde | DI Roskilde ...

direktør Jeanet Løgsted fra Scantox A/S, Køges kommunaldirektør Peter Frost og erhvervsudviklingschef Jens Abildlund, Køge Kommune. Foto: Helen...